← Open Payments lookup

SHANNON TIMMERMAN: Open Payments

NPI 1821605346 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,883 in 93 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $781 · 2025 $1,883

Food & beverage: $1,883
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC25$408
Janssen Biotech, Inc.12$389
ABBVIE INC.25$351
Madrigal Pharmaceuticals6$246
QOL Medical, LLC4$95
Regeneron Healthcare Solutions, Inc.4$89
Ipsen Biopharmaceuticals, Inc4$80
GENZYME CORPORATION2$50
Takeda Pharmaceuticals U.S.A., Inc.3$49
Gilead Sciences, Inc.2$35

Products named: XIFAXAN, TREMFYA, REZDIFFRA, RINVOQ, DUPIXENT, Sucraid, LINZESS, IQIRVO.

Industry payments across GA — which companies pay providers there.